TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06480981

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Noribogaine
Description: Noribogaine capsules
Study: NCT05504226

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
Description: To be orally administered once daily for 52 weeks.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Teneligliptin Placebo Oral Tablet
Description: To be orally administered once daily for 52 weeks. This arm will be switched to teneligliptin from week 24.
Study: NCT05246501

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation
Description: A case scenario with a diagnosis of dementia was used in the study. The scenario consisted of preliminary preparation, implementation and evaluation parts. Psychiatric nursing laboratory practice was applied to the students in the scenario study group. An elderly female standard patient who was diagnosed with dementia took part in the scenario. During this simulation, students were expected to perform mental state examination of the patient, use therapeutic communication techniques and ensure environmental safety.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: No simulation
Description: The students in the control group did not receive simulation training.
Study: NCT04750954

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo CT

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lutetium Lu 177 Dotatate
Description: Given IV

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo MRI

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peposertib
Description: Given PO
Study: NCT05001152

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozanimod
Description: Taste assessment
Study: NCT05035030

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Odevixibat
Description: Odevixibat is a small molecule and selective inhibitor of IBAT.
Study: NCT05695443

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing
Description: This study investigates the effects of an intervention based on Motivational Interviewing (MI) on oral hygiene, oral cleaning routines, and attitudes towards own oral health. The first step is for the dental staff to ask open questions to the prisoner about their oral health or oral health behavior. The next step is to confirm to the prisoner what he or she is doing. The third step is called reflection. At this stage, dental staff tries to provide reflections on what the prisoner have said, for example by repeating what the prisoner have said or say the same using synonyms (simple reflection), by extracting the underlying opinion or feeling (complex reflection), or by illuminate both negative and positive sides of the situation (double sided reflection). The final step is to summarize the conversation. In addition, the intervention includes a change plan, in which the prisoner and dental staff agrees on specific behavior that the prisoner should follow based on the MI conversation.
Study: NCT06374160

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Exercise

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Description: Exercise
Study: NCT06417255

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: kinesiotape application
Description: The strips used for kinesiological taping can be applied by giving different shapes. These shapes are I, Y, X, ring (donut), rake and net

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: foam roller application
Description: In the foam roller group, Actifoam brand non-serrated foam rollers with a size of 15x90 cm were used.
Study: NCT06790290

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Formulation B
Description: IVT PCV-25
Study: NCT05806814

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Description: Three doses of Sipuleucel-T, each containing a minimum of 50 million autologous CD54+ cells activated with PAP-GM-CSF, given at week 0, 2, and 12-14.
Study: NCT05924204

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Photobiomodulation
Description: Application of photobiomodulation

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Simulation of Photobiomodulation
Description: Simulation of photobiomodulation
Study: NCT06355596

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Virtual teaching
Description: Virtual teaching of laparoscopic skills

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Virtual teaching
Description: Virtual teaching of laparoscopic skills
Study: NCT06283940

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapist-led exercise based cardiac rehabilitation (PT-X)
Description: Individually prescribed centralcirculatory aerobic exercise and muscular endurance training twice a week for 60 minutes each session over 12 weeks in a hospital-based setting, and two sessions of home-based exercise recorded in an exercise diary.
Study: NCT06191874

Intervention type: OTHER
Intervention: Standard-of-care (SOC) surgery plan
Description: Use of SOC clinical planning tools to prepare for DBS (deep brain stimulation) surgery

Intervention type: OTHER
Intervention: Standard-of-care (SOC) surgery plan
Description: Use of SOC clinical planning tools to prepare for DBS (deep brain stimulation) surgery

Intervention type: OTHER
Intervention: HoloDBS hypothetical surgery plan
Description: Use of next generation visualization tools and surgical targeting models to hypothetically prepare for DBS (deep brain stimulation) surgery

Intervention type: OTHER
Intervention: HoloDBS hypothetical surgery plan
Description: Use of next generation visualization tools and surgical targeting models to hypothetically prepare for DBS (deep brain stimulation) surgery
Study: NCT06385795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: NOE-115
Description: NOE-115 is an investigational monoamine modulator which has potential anti-inflammatory activity.
Study: NCT06790290

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Formulation C
Description: IVT PCV-25

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Formulation D
Description: IVT PCV-25

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Prevnar20
Description: 20 valent pneumococcal conjugate vaccine
Study: NCT06790264

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 68Ga-FAPi-46 PET/CT
Description: Study participants will undergo baseline assessments at enrollment with 68Ga-FAPi-46 PET/CT
Study: NCT05843578

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGMB-129
Description: Oral capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AGMB-129
Description: Oral capsule

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Matching oral capsule
Study: NCT06790550

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Music Therapy
Description: Music will be played during the insulin injection process
Study: NCT06791876

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nurture and Play (NnP)
Description: The NnP group Intervention is a group-based, manualized parenting intervention initiated during pregnancy and continued into the postnatal period until infant age seven months. The program is designed to enhance parenting abilities focusing on three domains: Emotional availability, parental reflective functioning, and the ability to regulate own emotions. During NnP, the parents are supported in enhancing their emotional availability through caring and playing activities.~The intervention has been developed in Finland by Dr. Saara Salo and colleagues and tested in a randomized controlled trial among pregnant women with depression and it is now being implemented in Finland. The results from the study showed that mothers in the intervention group showed more emotional availability and higher levels of reflective functioning and experienced fewer depressive symptoms compared to mothers in the control group.
Study: NCT06789627

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: RPD with PEEK framework
Description: Indirectly CAD/CAM produced PEEK framework

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: RPD with metallic framework
Description: Indirectly CAD/CAM produced metallic RPD
Study: NCT06784531

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mitoquinone mesylate (MitoQ)
Description: Four 20 mg MitoQ capsules (80 mg total) are ingested orally.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Mitoquinone mesylate (MitoQ)
Description: Four 20 mg MitoQ capsules (80 mg total) are ingested orally.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Four placebo (microcrystalline cellulose) capsules are ingested orally.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Four placebo (microcrystalline cellulose) capsules are ingested orally.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Water Hand Immersion
Description: Volunteers place one hand in cold (54°F) water for 30 minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cold Water Hand Immersion
Description: Volunteers place one hand in cold (54°F) water for 30 minutes.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold Air Exposure
Description: Volunteers sit in cold (41°F) air for 90 minutes.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Cold Air Exposure
Description: Volunteers sit in cold (41°F) air for 90 minutes.
Study: NCT06784674

Intervention type: OTHER
Intervention: No intervention
Description: Observational study
Study: NCT06790225

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose-dependent Insulinotropic Polypeptide (GIP)
Description: Recombinant human GIP (1-42)

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Glucose-dependent Insulinotropic Polypeptide (GIP)
Description: Recombinant human GIP (1-42)
Study: NCT06785363

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pumped technique for ilio-lumbar ligament release
Description: Patient position: the patient lying supine or side lying Therapist position: standing on one side of patient. Hand grip: one hand placed on posterior region of iliac crest (close to attachment of ilio-lumbar ligament) while other hand stabilize the medial part of thigh. Therapist force: therapist pulling patient's thigh posteriorly.
Study: NCT05253963

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Continuous Positive Airway Pressure
Description: Continuous Positive Airway Pressure will be used during the second night of polysomnography .
Study: NCT06785363

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Hot Packs
Description: postnatal women will be treated by hot packs for 20 minutes three times per week for 8 weeks.
Study: NCT06791434

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fixed Dose Combination Etoshine MR tablets
Description: Composition per tablet: Etoricoxib 60 mg + Thiocolchicoside 4 mg

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fixed Dose Combination Etoshine MR tablets
Description: Composition per tablet: Etoricoxib 60 mg + Thiocolchicoside 4 mg

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Thin needle insertion

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiotherapy
Description: Exercises

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Description: Exercises
Study: NCT06388421

Intervention type: OTHER
Intervention: Prospective study assessments
Description: Patients will complete prospective assessments at 6- and 12-month intervals for up to 5 years. There will be 1 check in at the first 3 months of enrollment. Follow up visits will include a ±45 day visit window. If an assessment is performed within 45 days of the visit window as part of the patient's standard of care, those values will be used in place of a prospective assessment.
Study: NCT06019039

Intervention type: DRUG
Intervention: Normal Saline Flush
Description: Five milliliters of sterile saline will be administered as a flush through the needle while recording the color flow doppler images. The same procedure will be repeated with a slow injection of 5 mL of saline. The speed of injection will not be standardized.

Intervention type: DEVICE
Intervention: Doppler
Description: All color flow Doppler images will be performed with a Phillips CX50 ultrasound machine using a 5.0 MHz a low frequency curvilinear US probe. A two-dimensional transverse interspinous view was used to visualize the posterior complex (ligamentum flavum, epidural space and dura). After loss of resistance to normal saline, the color flow Doppler function will be turned on to examine flow through the epidural needle tip.~The ultrasound probe was positioned in the transverse axis slightly below the epidural needle but still in the interspinous space .
Study: NCT06273722

Intervention type: DEVICE
Intervention: Vivosight Multi-beam Swept-Source Frequency Domain OCT scanner
Description: Vivosight Multi-beam Swept-Source Frequency Domain OCT scanner (Michelson Diagnostics Maidstone, Kent, UK; resolution \<7.5 µm lateral, \<5 µm axial; depth of focus 1.0 mm; scan area 6 × 6 mm).
Study: NCT04305769

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alanyl-glutamine
Description: The study agent is AQ, a dipeptide with a glutamine amino group joined to an alanyl residue. It has the following chemical structure: C8H15N3O4. It is a non-animal product available in the form of white crystals or crystalline powder. It is odorless, tasteless, stable and highly soluble.
Study: NCT06271265

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EXPAREL
Description: A single dose of EXPAREL Injectable Product via LIA

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: bupivacaine
Description: A single dose of 0.25% bupivacaine via LIA
Study: NCT06401889

Intervention type: OTHER
Intervention: Non-Interventional Study
Description: Non-interventional study
Study: NCT05638412

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: JASPER
Description: JASPER is a therapist and caregiver-mediated intervention that (1) targets the foundations of social communication, (2) uses naturalistic behavioral strategies to increase the rate and complexity of social communication and (3) includes caregivers as implementers of the intervention to promote generalization across settings and to ensure maintenance. This intervention is individualized and centered around two key developmental domains critical for social communication function: joint engagement and joint attention.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Psychoeducational Curriculum
Description: The psychoeducational modules will include written information about child development, communication and social interaction skills, behavioral principles for managing challenging behavior and strategies for teaching new skills. No direct caregiver-child mediated coaching will be provided. The material provided will be similar to what a pediatrician or developmental specialist may review as a part of routine care.
Study: NCT05160233

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standard implementation
Description: Brief clinician training and an implementation toolkit consisting of job aids, patient educational materials, scripted conversations, electronic health record tools, and a population management workbench.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching
Description: The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Coaching
Description: The clinic is provided access to a health coach who conducts outreach with patients. The health coach facilitates engagement with the digital therapeutic and encourages contact with the care team.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practice Facilitation
Description: A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Practice Facilitation
Description: A trained facilitator provides support for implementation by delivering the following interventions to clinic staff: Bolster Education, Audit and Provide Feedback, Support Plan-Do-Study-Act Cycles, Engage Others in Change.
Study: NCT05159167

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Baduanjin, a type of Qigong
Description: Baduanjin is very popular in China. There is increasing evidence to support its positive effects on health outcomes in various groups of people with physical and mental disorders.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Baduanjin, a type of Qigong
Description: Baduanjin is very popular in China. There is increasing evidence to support its positive effects on health outcomes in various groups of people with physical and mental disorders.
Study: NCT05151783

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: conventional physiotherapy
Description: Control group receivewill routine physical therapy including modalities like ultrasound (3 MHz continuous type; duration 10 minutes), heat modalities (apply to the involved region of shoulder joint shoulder for 10 minutes), shoulder ROM exercises, capsular stretching, and joint mobilization 5 times per week for four weeks. Duration of session will be 40 minutes.~All Maitland mobilization will be given in supine position. After giving glenohumeral (GH) joint distraction, GH caudal glide, GH dorsal glide, and GH ventral glide were given at a rate of 2-3/second oscillations for 1-2 minutes to patients. Grade I or II rhythmic oscillations will be applied in pain free movement.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: PNF technique
Description: Group will receive scapular PNF techniques with routine physical therapy explained above For PNF techniques, patients will be lying on unaffected shoulder. In this group, 20 repetitions of diagonal scapular Pattern (Anterior Elevation and Posterior Depression and Posterior Elevation and Anterior Depression) with 20 sec rest period will be given to patients. Preparatory instructions for the desired movement will be given to patients at the start of procedure. PNF facilitation techniques of RI (Rhythmic initiation) \& repeated contractions will be used in all patterns
Study: NCT06002581

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS real stimulation stage1
Description: In the first stage, the early treatment group use low-frequency rTMS real stimulation,

Intervention type: DEVICE
Group type: OTHER
Intervention: rTMS shame stimulation stage1
Description: In the first stage, the control group (delayed treatment group) all use sham stimulation.

Intervention type: DEVICE
Group type: OTHER
Intervention: rTMS real stimulation stage 2
Description: In the second stage, both the early treatment group and the control group (delayed treatment group) will be treated with true stimulation low-frequency rTMS.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: rTMS real stimulation stage 2
Description: In the second stage, both the early treatment group and the control group (delayed treatment group) will be treated with true stimulation low-frequency rTMS.
Study: NCT05127512

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Education Video
Description: A 6.47-minute education video was created by the research group based on American Urogynecology Society (AUGS) and International Urogynecologic Association (IUGA) patient education pamphlets. Participants in the intervention group will be asked to watch this video after completing a baseline knowledge questionnaire of pelvic floor disorders.
Study: NCT05573724

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AZD5305
Description: In Part A, the participants will receive a single dose of AZD5305 on Day 1 and Day 7.~In Part B, the participants will receive AZD5305 once daily.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: In Part A, the participants will receive Itraconazole twice daily on Day 4 and once daily on Days 5-12
Study: NCT04941703

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Citrate plus probiotic
Description: 296 ml magnesium citrate

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Magnesium Citrate plus probiotic
Description: 296 ml magnesium citrate